The shares of TEGNA Inc. have decreased by more than -28.34% this year alone. The shares recently went down by -3.44% or -$0.36 and now trades at $10.09. The shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), has slumped by -17.95% year to date as of 05/03/2018. The shares currently trade at $41.27 and have been able to report a change of -5.08% over the past one week.
The stock of TEGNA Inc. and Ionis Pharmaceuticals, Inc. were two of the most active stocks on Thuday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.Next 5Y EPS Growth: 6.00% versus 40.00%
When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that TGNA will grow it’s earning at a 6.00% annual rate in the next 5 years. This is in contrast to IONS which will have a positive growth at a 40.00% annual rate. This means that the higher growth rate of IONS implies a greater potential for capital appreciation over the years.Profitability and Returns
Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. TGNA has an EBITDA margin of 33.57%, this implies that the underlying business of TGNA is more profitable. The ROI of TGNA is 10.70% while that of IONS is 13.90%. These figures suggest that IONS ventures generate a higher ROI than that of TGNA.Cash Flow
The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, TGNA’s free cash flow per share is a positive 0.34.Liquidity and Financial Risk
The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for TGNA is 2.00 and that of IONS is 5.20. This implies that it is easier for TGNA to cover its immediate obligations over the next 12 months than IONS. The debt ratio of TGNA is 3.02 compared to 1.84 for IONS. TGNA can be able to settle its long-term debts and thus is a lower financial risk than IONS.Valuation
TGNA currently trades at a forward P/E of 6.67, a P/B of 2.19, and a P/S of 1.19 while IONS trades at a forward P/E of 375.18, a P/B of 15.57, and a P/S of 10.15. This means that looking at the earnings, book values and sales basis, TGNA is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.Analyst Price Targets and Opinions
The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of TGNA is currently at a -36.94% to its one-year price target of 16.00. Looking at its rival pricing, IONS is at a -33.44% relative to its price target of 62.00.
When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), TGNA is given a 2.20 while 2.80 placed for IONS. This means that analysts are more bullish on the outlook for IONS stocks.Insider Activity and Investor Sentiment
Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for TGNA is 5.51 while that of IONS is just 9.00. This means that analysts are more bullish on the forecast for TGNA stock.
The stock of Ionis Pharmaceuticals, Inc. defeats that of TEGNA Inc. when the two are compared, with IONS taking 5 out of the total factors that were been considered. IONS happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, IONS is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for IONS is better on when it is viewed on short interest.